HDL Therapeutics

Device company HDL Therapeutics eyes public listing in $480m SPAC deal
Pharmaphorum
Mon, 08/14/23 - 10:20 am
Medtech
SPAC
HDL Therapeutics
NASDAQ
atherosclerotic plaques